1.
Andrade Vera K, Fischman L, Bambés G, Bartolomeo S, Carreras Vescio L. Immunohematological finding anticipates refractoriness to treatment with daratumumab in a patient with multiple mieloma. RH [Internet]. 2019 Jan. 15 [cited 2026 Nov. 9];22(2):185-7. Available from: https://revistahematologia.com.ar/index.php/Revista/article/view/25